PEPTONIC MEDICAL
PEPTONIC medical AB (publ), a medical technology company, develops and sells intimate self-care products for women. The company offers products under the VagiVital brand, including a moisturizing gel for atrophy; an intimate calming gel for rapid relief of itching and irritation; moisturizing lubricant; a pH-balancing intimate wash/conditioner; self-test kits for diagnosing pre-menopause, menopau… Read more
Market Cap & Net Worth: PEPTONIC MEDICAL (28L)
PEPTONIC MEDICAL (F:28L) has a market capitalization of $33.87 Million (€33.00 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #26855 globally and #2938 in its home market, demonstrating a 300.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PEPTONIC MEDICAL's stock price €0.00 by its total outstanding shares 20624009514 (20.62 Billion).
PEPTONIC MEDICAL Market Cap History: 2021 to 2026
PEPTONIC MEDICAL's market capitalization history from 2021 to 2026. Data shows change from $690.14 Million to $33.87 Million (-56.68% CAGR).
PEPTONIC MEDICAL Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PEPTONIC MEDICAL's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 28L by Market Capitalization
Companies near PEPTONIC MEDICAL in the global market cap rankings as of March 19, 2026.
Key companies related to PEPTONIC MEDICAL by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
PEPTONIC MEDICAL Historical Marketcap From 2021 to 2026
Between 2021 and today, PEPTONIC MEDICAL's market cap moved from $690.14 Million to $ 33.87 Million, with a yearly change of -56.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €33.87 Million | +700.00% |
| 2025 | €4.23 Million | 0.00% |
| 2024 | €4.23 Million | -95.24% |
| 2023 | €88.91 Million | -39.13% |
| 2022 | €146.07 Million | -78.83% |
| 2021 | €690.14 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PEPTONIC MEDICAL was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.87 Million USD |
| MoneyControl | $33.87 Million USD |
| MarketWatch | $33.87 Million USD |
| marketcap.company | $33.87 Million USD |
| Reuters | $33.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.